Scinovex
review Open AccessTop 1% cited

Updated Functional Classification of β-Lactamases

Antimicrobial Agents and Chemotherapy · 2009 · Vol. 54(3) · pp. 969–976
Karen BushGeorge A. Jacoby

Abstract

Two classification schemes for beta-lactamases are currently in use. The molecular classification is based on the amino acid sequence and divides beta-lactamases into class A, C, and D enzymes which utilize serine for beta-lactam hydrolysis and class B metalloenzymes which require divalent zinc ions for substrate hydrolysis. The functional classification scheme updated herein is based on the 1995 proposal by Bush et al. (K. Bush, G. A. Jacoby, and A. A. Medeiros, Antimicrob. Agents Chemother. 39:1211-1233, 1995). It takes into account substrate and inhibitor profiles in an attempt to group the enzymes in ways that can be correlated with their phenotype in clinical isolates. Major groupings generally correlate with the more broadly based molecular classification. The updated system includes group 1 (class C) cephalosporinases; group 2 (classes A and D) broad-spectrum, inhibitor-resistant, and extended-spectrum beta-lactamases and serine carbapenemases; and group 3 metallo-beta-lactamases. Several new subgroups of each of the major groups are described, based on specific attributes of individual enzymes. A list of attributes is also suggested for the description of a new beta-lactamase, including the requisite microbiological properties, substrate and inhibitor profiles, and molecular sequence data that provide an adequate characterization for a new beta-lactam-hydrolyzing enzyme.

Antibiotic Resistance in BacteriaAntibiotic Use and ResistancePneumonia and Respiratory InfectionsSerineEnzymeClassification schemeSubstrate (aquarium)Sequence (biology)Substrate specificityHydrolysisChemistryStereochemistryBiochemistry

MeSH terms

Anti-Bacterial Agentsbeta-LactamasesGram-Negative BacteriaHumansDrug Resistance, Bacterialbeta-Lactams
Citations
2,234
FWCI
21.34
field-weighted impact
References
73
Percentile
100%
vs. same field & year
Citations per year
Cited by
Carbapenems: Past, Present, and Future
Antimicrobial Agents and Chemotherapy · 2011 · 1,468 citations
Antimicrobial Resistance in ESKAPE Pathogens
Clinical Microbiology Reviews · 2020 · 1,952 citations
Three Decades of β-Lactamase Inhibitors
Clinical Microbiology Reviews · 2010 · 1,608 citations
Past and Present Perspectives on β-Lactamases
Antimicrobial Agents and Chemotherapy · 2018 · 801 citations
The Comprehensive Antibiotic Resistance Database
Antimicrobial Agents and Chemotherapy · 2013 · 2,238 citations
References
A standard numbering scheme for the class A <i>β</i>-lactamases
Biochemical Journal · 1991 · 1,069 citations
Carbapenemases: the Versatile β-Lactamases
Clinical Microbiology Reviews · 2007 · 2,447 citations
Emergence of Oxacillinase-Mediated Resistance to Imipenem in<i>Klebsiella pneumoniae</i>
Antimicrobial Agents and Chemotherapy · 2003 · 963 citations
AmpC β-Lactamases
Clinical Microbiology Reviews · 2009 · 2,108 citations
OXA-type carbapenemases
Journal of Antimicrobial Chemotherapy · 2006 · 502 citations
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Antimicrobial Agents and Chemotherapy · 2003 · 1,463 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.